Unknown

Dataset Information

0

Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease.

ABSTRACT:

SUBMITTER: Fernandez-Nebro A 

PROVIDER: S-EPMC1860098 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients.
| S-EPMC6244106 | biostudies-other
Unknown IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location.
| S-EPMC2726456 | biostudies-literature
Unknown Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.
| S-EPMC7476637 | biostudies-literature
Clinical Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
| 2161631 | ecrin-mdr-crc
Unknown Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNF? Treatment for Crohn's Disease.
| S-EPMC6176896 | biostudies-literature
Unknown Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis.
| S-EPMC6981109 | biostudies-literature
Unknown Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial.
| S-EPMC2517154 | biostudies-literature
Unknown Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
| S-EPMC6849553 | biostudies-literature
Unknown Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?
| S-EPMC5369733 | biostudies-other
Unknown Anti-NKG2D mAb: A New Treatment for Crohn's Disease?
| S-EPMC5618646 | biostudies-other